Compare AURA & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | PD |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.4M | 782.0M |
| IPO Year | 2021 | 2019 |
| Metric | AURA | PD |
|---|---|---|
| Price | $7.60 | $9.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $20.00 | $12.63 |
| AVG Volume (30 Days) | 661.7K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 416.95 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $492,546,000.00 |
| Revenue This Year | N/A | $3.58 |
| Revenue Next Year | N/A | $2.88 |
| P/E Ratio | ★ N/A | $76.77 |
| Revenue Growth | N/A | ★ 5.36 |
| 52 Week Low | $4.73 | $5.70 |
| 52 Week High | $9.54 | $17.45 |
| Indicator | AURA | PD |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 66.33 |
| Support Level | $5.18 | $6.08 |
| Resistance Level | $7.81 | $10.70 |
| Average True Range (ATR) | 0.50 | 0.45 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 99.37 | 85.18 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.